FDA Inspection 1027719 — LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC

LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC — FEI 3008307571

The FDA completed an inspection of LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC on September 27, 2017 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Branchburg, NJ (United States)